![Udi Eyal Fima](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Udi Eyal Fima
Keine laufenden Positionen mehr
Karriereverlauf von Udi Eyal Fima
Ehemalige bekannte Positionen von Udi Eyal Fima
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NatSpears Ltd.
![]() NatSpears Ltd. Hospital/Nursing ManagementHealth Services NatSpears Ltd. specializes in cancer therapeutics. The company is based in Tel Aviv, Israel. | Präsident | - | - |
Enlivex Therapeutics Ltd. /Old/
![]() Enlivex Therapeutics Ltd. /Old/ Medical SpecialtiesHealth Technology Enlivex Therapeutics Ltd. develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions. It produces treatment devices for CAR-T cancer treatment procedures, Graft-versus-Host disease resulting from bone-marrow transplantations, solid organ transplantations and an assembly of autoimmune and inflammatory conditions, such as Crohn’s disease, rheumatoid arthritis, gout, multiple sclerosis and other disorders. The company was founded by Dror Mevorach in 2005 and is headquartered in Jerusalem, Israel. | Direktor/Vorstandsmitglied | - | - |
Vorstandsvorsitzender | - | - | |
Präsident | - | - | |
OPKO Biologics Ltd.
![]() OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | Geschäftsführer | 12.12.2012 | - |
Corporate Officer/Principal | 01.11.2005 | 12.12.2012 |
Ausbildung von Udi Eyal Fima
Ben-Gurion University of the Negev | Doctorate Degree |
Statistik
International
Israel | 5 |
Operativ
President | 2 |
Chief Operating Officer | 1 |
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
OPKO Biologics Ltd.
![]() OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | Health Technology |
Enlivex Therapeutics Ltd. /Old/
![]() Enlivex Therapeutics Ltd. /Old/ Medical SpecialtiesHealth Technology Enlivex Therapeutics Ltd. develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions. It produces treatment devices for CAR-T cancer treatment procedures, Graft-versus-Host disease resulting from bone-marrow transplantations, solid organ transplantations and an assembly of autoimmune and inflammatory conditions, such as Crohn’s disease, rheumatoid arthritis, gout, multiple sclerosis and other disorders. The company was founded by Dror Mevorach in 2005 and is headquartered in Jerusalem, Israel. | Health Technology |
NatSpears Ltd.
![]() NatSpears Ltd. Hospital/Nursing ManagementHealth Services NatSpears Ltd. specializes in cancer therapeutics. The company is based in Tel Aviv, Israel. | Health Services |
- Börse
- Insiders
- Udi Eyal Fima
- Erfahrung